Introduction
Neonatal infections currently cause about 1.6 million deaths per year in developing countries. Sepsis and meningitis are responsible for most of these deaths (1) . Late-onset sepsis (LOS) is a challenging complication that affects other morbidities, length of hospitalization, cost of care, and mortality rates (2) . Improvements in outcome and successful treatment depend largely on early initiation of appropriate antibiotic therapy.
The aetiology of neonatal sepsis in developing countries differs from that in developed countries in the pattern of etiological bacteria and their antibiotic susceptibility (3) . In developed countries Group B Streptococcus, (GBS) is a common aetiological agent, but the burden in the developing world is less clear (4) . Ampicillin and gentamicin are used as the first-line empirical treatment and the decision is traditionally based on the pathogenic flora commonly responsible in each neonatal unit. Antimicrobial susceptibility may vary between units and there is an increasing resistance rate of gram-negative bacteria to ampicillin, gentamicin and cefotaxime worldwide (5) . Suspected bacterial infection is the main cause of neonatal admissions to hospitals in developing countries. Hospital-based studies suggest that most infections beyond the age of 72 hours are due to gram-negative pathogens, and the majority are likely to be environmentally rather than maternallyacquired. Moreover, there is a significant similarity between the causative organisms for early and late-onset sepsis in developing countries. The key pathogens are: Klebsiella species, Escherichia coli, Staphylococcus aureus and Streptococcus pyogenes (6) .
Since in the literature there are no epidemiological data on neonatal sepsis and on the antibiotic susceptibility of the responsible bacteria in Bosnia and Herzegovina, this study was undertaken to describe the situation in a tertiary care hospital, providing neonatal intensive care services.
Methods

Clinical setting
The University Clinical Centre is a teaching hospital with 1373 beds, serving a population of 510,353. It is the referral centre for all inborn neonates (about 4500 deliveries annually) and for those born in the nearby hospitals, serving also for paediatric surgery when indicated. The NICU of the Department of Paediatrics provides intensive care for up to 18 patients. It has an area of 293 m 2 , has one common and two single isolation rooms. Visitation of mothers and visitors is limited to once per day. There is a handwashing station adjacent to the NICU, where all visitors are required to wash their hands. For all newborns, prophylactic antibiotics are routinely used (ampicillin and gentamicin) before entering the NICU or surgery, regardless of the presence of risk factors for infections, although it is questionable.
Study design and data collection
This single centre, observational study was carried out from July 1, 2012 to June 30, 2013 and included a total of 200 critically ill hospital-born neonates, admitted to the Neonatal Intensive Care Unit (NICU) at the Children's Hospital in Tuzla, Bosnia and Herzegovina. This study had a prospective design. The study was approved by the Ethical Committee of the University Clinical Centre, Tuzla. For each enrolled neonate the demographic variables collected included: sex, birth weight (BW) and gestational age (GA). Intrauterine growth restriction was defined as birth weight for GA (BW less than 10 th percentile for GA). Other demographic data included the clinical condition of the neonates at the time of admission to the unit [the presence of major congenital malformations (7)], 5-minute Apgar score, age at admission, rectal temperature on entry; need for intubation, mechanical ventilation or exogenous surfactant, venous catheterization, lipid-containing parenteral nutrition, peripheral venous lines, continuous enteral feeding by tube, need for bladder catheterization for surgery; maternal risk factors were: fever, prolonged rupture of membrane, meconium stained-amniotic fluid, clinical signs, laboratory tests and obstetric procedures.
Definitions of sepsis
Sepsis was defined as confirmed or clinically suspected. Confirmed sepsis was defined as the presence of at least two clinical signs and/or two laboratory findings with a positive blood culture. Sepsis was defined as suspected (or clinical sepsis) when the same clinical or laboratory signs were present with a negative blood culture. Clinical signs of sepsis included: fever (rectal temperature >38°C), tachycardia (heart rate >180 beats per minute) or bradycardia (heart rate <100 beats per minute), apnoea lasting >20 seconds, lethargy, feeding problems, gastric billiary stasis, hemodynamic abnormalities, convulsions, and hypotonia. Laboratory signs: leucopoenia (white blood cell count <5.000 mm3) or leucocytosis (white blood cell count >20.000 mm 3 ), low platelet count (platelets <100.000 mm 3 ), blood C-reactive protein level >1.5 mg/dL, fibrinogen >150 mg/dL, white blood cell immature/total ratio ≥0.2, metabolic acidosis (base excess ≥7 mmol/L). Sepsis acquired in the hospital that became symptomatic after hospital discharge or after the first 72 hours of life is defined as late-onset sepsis (LOS) (8) . Early-onset sepsis (EOS) presented within 72 hours of life with clinical and laboratory symptoms, in the presence or absence of maternal risk factors.
Microbiological analysis
Blood culture was obtained for each neonate with signs of sepsis, by the method described by Buttery (9) . The blood specimen was further inoculated into a BACTEC Peds plus/F culture vial (BACTEC, Becton Dickinson, USA) and the inoculated cultures were incubated as soon as possible in the BACTEC 9120 instrument for up to five days as recommended by Becton Dickinson Microbiological Systems (10) . Sensitivity of isolated bacteria to various antibiotics was assessed by the modified Kirby and Bauer method on Mueller-Hilton agar, according to the Clinical and Laboratory Standard Institute guidelines, using an automated Vitek 2 Compact system (11).
Statistical analysis
Continuous variables were described with mean ± standard deviation or as medians and interquartile ranges -IQR. Inferences about categorical data were analyzed using the chi-square or Fisher exact test, as appropriate. The main outcome measure of the analysis was LOS onset (suspected or confirmed) during hospitalization in the NICU, in relation to the other variables recorded. Rates of infection were calculated dividing the number of infections occurring during time of exposure by the total of exposure time. For each specific procedure the time of exposure was the time of administration of the procedure. The incidence density (ID) of infection was the ratio between the number of episodes of infection divided by the total sum of days at risk during the hospital stay (PD: person-days at risk), and the relative risk of infection associated with each variable was the ratio between the incidence rate in the risk-based group and the incidence rate in the reference group. Analyses were performed by IBM SPSS Statistics 22 and MedCalc statistical software for Windows Version 13 -14.10.2; p values were considered statistically significant at a value of 0.05.
Results
Two hundred infants were admitted to the NICU. Mean BW was 2915 ± 968.74 g; of these 200 infants, 31 were very low birth weight (VLBW). The numbers of infants in each gestational age and birth weight category are shown in Table 1 .
Among the 200 neonates observed in the NICU, 136 had at least one episode of neonatal sepsis. The organisms responsible for early and late onset sepsis and their antibiotic sensitivity patterns are shown in Tables  2 and 3 .
The incidence of early-onset neonatal sepsis was 28.7% (39/200) and the incidence of LOS was 71.3% (97/200). There were 110 episodes of LOS, yielding an incidence density of 41.6 per 1000 patient days (110/2646). Seven of 200 neonates (3.5%) had two epi- The incidence density of sepsis in NICU by selected clinical characteristics and invasive procedures is shown in Table 4 . VLBW, extreme prematurity (<28 gestational age), 5-minute Apgar score ≤3, assisted ventilation, the presence of a central venous catheter and surgical intervention were all significantly associated with a higher incidence of LOS sepsis 
Discussion
To our knowledge, this is the first prospective observational study that describes the rate, aetiology and some of the risk factors of neonatal sepsis in an NICU in Bosnia and Herzegovina. The sudy by Hadzimuratovic et al. was limited to premature infants with congenital heart disease, and found a higher risk of acquiring sepsis during hospitalization in an NICU (12) . The high incidence and overall mortality rate from sepsis, especially among VLBW infants, and the high incidence density of LOS are in line with investigations from developing countries (13) (14) (15) . The most common causes of death in the neonatal period in developing countries are infections (1). Timely microbiological surveillance and assessment of antimicrobial resistance is a key component in decreasing the rate of neonatal sepsis and the associated mortality. There are a number of important gaps in our knowledge and a lack of studies looking at simple and sustainable interventions to reduce the burden of neonatal sepsis. The lack of culture driven antimicrobial therapy and limited consistent infection control practices are likely responsible for the high incidence rates of neonatal sepsis and mortality.
There are no comprehensive studies available in developing counties, because no National Nosocomial Infection Surveillance Systems (NNISS), which develop surveillance and preventive strategies to break down nosocomial infections, have been implemented. To implement such NNISS could be critical in abating this clinical and public health problem.
There is a general lack of precision in defining sepsis in developing countries. Micribiological results in many developing countries may require several days to become positive. Moreover, in neonates the incidence of positive blood cultures in the course of sepsis often does not reach 50% of samples (16) . In our unit, rates of resistance for gram-negative and gram-positive bacteria were high, leading to a great deal of concern with respect to infection control and antibiotic prescribing practices. Gramnegative bacterias were more frequently isolated, which is a common finding from countries with low resources, overcrowding and poor staffing patterns in hospitals (17, 18) . They were even highly resistant to ampicillin and gentamicin. In our unit there has been a questionable routine practice to start antibiotics for all new-borns regardless of clinical signs. Cephalosporins and an aminoglicoside (amikacin) have been the first line therapy because of the high resistance to recommended empirical therapy with ampicillin and gentamycin. A preponderance of enterobacteria has been noted in other similar clinical settings (19, 20) . This problem might be prevented through limitation of the use of the latest generation of cephalosporin, and specific prevention measures, such as hand washing. The current standard practice of unselective use of antibiotic therapy for every new-born entering the NICU is one that needs revision.
Low birth weight and prematurity increase the risk of neonatal sepsis, but in our study it did not reach statistical significance. In other studies, 20% of VLBW preterm infants experienced a serious systemic infection. Furthermore, the mortality rate was as much as threefold higher than their counterparts without sepsis during their hospitalization (21) . In this study, the overall mortality rate associated with sepsis was high for the entire group of infected babies. In the group of VLBW the incidence was twofold higher. However, there were only 31 VLBW neonates in our population.
Among the biological characteristics, extreme prematurity (<28 gestational age), and 5-minute Apgar score ≤3 were risk factors for LOS among our patients, confirming the data from major literature on this topic (22) . Among the therapeutic procedures associated with LOS, assisted ventilation, the presence of a central venous catheter and surgical intervention markedly increased the risk of infection. Moreover, invasive procedures in association with prematurity are risk factors for acquiring sepsis, especially in settings with a high intensity of colonization pressure, which is characteristic for developing countries (23, 24) . The current standard practice of unselective use of antibiotic therapy for every new-born entering the NICU may be a limitation and it needs to be modified.
Conclusion
A high incidence and mortality rate from sepsis especially in VLBW infants, a high incidence density of LOS, a low rate of positive blood culture and a higher frequency of isolated, very resistant gram-negative bacteria are presented in this study. The paucity of data in the medical literature on neonatal sepsis in Bosnia and Herzegovina is a matter of concern for all those who work with neonates, especially in NICUs. Another aspect that must be addressed is the rational use of antibiotics. Specific guidelines for prescribing antibiotic therapy and applying invasive procedures for neonates in NICUs are important means to limit the development of resistant pathogens. Understanding the aetiology and epidemiology of neonatal sepsis and their changes over time is a key component in the reduction of sepsis and mortality of neonates in Bosnia and Herzegovina. Only a multidisciplinary approach, with contributions from neonatologists, infection control practitioners and microbiologists, will reduce the incidence of neonatal sepsis. Limited-resource countries need to reach the quality of health care and patient safety that we find in developed countries.
What is already known on this topic
Neonatal bacterial sepsis continues to be major cause of morbidity and mortality in the developing world. Differences in epidemiology between developed and developing countries have been identified. 
What this study adds
